Media Room
Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.
For media inquiries, please contact us at [email protected].
-
Media Room Article
Cancer Research Institute to Honor Scientists for Groundbreaking Discoveries Leading to New Immune-Based Strategies that Target Gasdermins in Cancer Treatment
CRI to give the 2022 William B . Coley Award for Distinguished Research in Basic and Tumor… -
Media Room Article
Cancer Research Institute to Host Second Annual Spanish-Language Virtual Immunotherapy Patient Summit
The free online event will connect cancer patients and caregivers with the latest promising research findings shared… -
Media Room Article
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer… -
Media Room Article
Cellular Cancer Immunotherapy Development Evolves, Expands with New Technologies and Targets
Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends…
-
Media Room Article
Cancer Research Institute Hosts 10th Annual Cancer Immunotherapy Month™ Celebrating Lifesaving Discovery in Immuno-Oncology
Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy…
-
Media Room Article
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian…
-
Media Room Article
Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points…
-
Media Room Article
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering: “This Technology Will Play a Big Role in Cancer Treatment”
Four Key Scientists Behind the Vaccines to Share Virtual Stage at November 10 Event; Katalin Karikó, Ugur…
-
Media Room Article
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial
The first patients have enrolled in a platform clinical trial, called REVOLUTION, testing combination immunotherapy in patients…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.